B-type natriuretic peptides are reliable markers of cardiac strain in CKD pediatric patients

被引:0
作者
Choni Rinat
Rachel Becker-Cohen
Amiram Nir
Sofia Feinstein
Nurit Algur
Efrat Ben-Shalom
Benjamin Farber
Yaacov Frishberg
机构
[1] The Hadassah-Hebrew University School of Medicine,Pediatric Nephrology, Shaare Zedek Medical Center
[2] The Hadassah-Hebrew University School of Medicine,Pediatric Cardiology, Shaare Zedek Medical Center
[3] Shaare Zedek Medical Center,Clinical Laboratories
来源
Pediatric Nephrology | 2012年 / 27卷
关键词
Chronic kidney disease; Pediatric; B-type natriuretic peptide; Troponin; Heart;
D O I
暂无
中图分类号
学科分类号
摘要
Myocardial damage and strain are common in children with chronic renal failure. The most prevalent pathologies, as defined by echocardiography, are left ventricular hypertrophy (LVH), diastolic and systolic dysfunction, and altered LV geometry. Troponin I and T, as well as B-type natriuretic peptide (BNP) and its cleavage fragment NT-proBNP, are known to be good markers of myocardial damage and stress, respectively, in the general adult population and among those with chronic kidney disease (CKD). In this study we measured the levels of troponins I and T, BNP, and NT-proBNP in a group of children and young adults with CKD stages 3–5 and determined their respective correlations with echocardiographic and laboratory abnormalities. BNP and NT-proBNP levels and their log values correlated well with the following parameters: diastolic blood pressure, estimated glomerular filtration rate, time-averaged hemoglobin levels, and LV mass. Both BNP and NT-proBNP levels, but not those of either troponin, were found to be reliable surrogate markers of strained hearts, defined as having LVH or diastolic or systolic dysfunction, in the pediatric CKD stages 3–4 group. The log NT-proBNP value was also found to be a good marker of cardiac strain in the CKD stage 5 group of patients. Serum BNP and NT-proBNP threshold concentrations of 43 and 529 pg/ml, respectively, were found to have the best sensitivity and specificity in predicting strained hearts. Based on these findings, we conclude that both BNP and NT-proBNP levels, but not those of troponins I and T, can serve as inexpensive, simple, and reliable markers of stressed hearts in the pediatric CKD patient population.
引用
收藏
页码:617 / 625
页数:8
相关论文
共 148 条
[1]  
Zoccali C(2002)Cardiorenal risk as a new frontier of nephrology: research needs and areas for intervention Nephrol Dial Transplant 17 50-54
[2]  
Greenbaum LA(2009)Current advances in chronic kidney disease in children: growth, cardiovascular and neurocognitive risk factors Semin Nephrol 29 425-434
[3]  
Warady BA(2006)Risk factors for cardiovascular disease in children and young adults after renal transplantation Clin J Am Soc Nephrol 1 1284-1292
[4]  
Furth SL(2006)Cardiovascular risk reduction in high-risk pediatric patients: a scientific statement from the American Heart Association Expert Panel on Population and Prevention Science; the Councils on Cardiovascular Disease in the Young, Epidemiology and Prevention, Nutrition, Physical Activity and Metabolism, High Blood Pressure Research, Cardiovascular Nursing, and the Kidney in Heart Disease; and the Interdisciplinary Working Group on Quality of Care Circulation 114 2710-2738
[5]  
Becker-Cohen R(1999)Cardiac structure and function in patients with chronic renal failure Pediatr Nephrol 13 951-965
[6]  
Nir A(2003)Serum cardiac troponin and subclinical cardiac status in pediatric chronic renal failure Pediatrics 112 79-86
[7]  
Rinat C(2002)Breathing Not Properly Multinational Study Investigators. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure N Engl J Med 347 161-167
[8]  
Feinstein S(2004)N-terminal-pro-brain natriuretic peptide predicts outcome after hospital discharge in heart failure patients Circulation 110 2168-2174
[9]  
Algur N(2007)N-terminal pro brain natriuretic peptide predicts mortality in patients with end-stage renal disease in hemodialysis Kidney Int 71 548-554
[10]  
Farber B(2004)The Fourth Report on the Diagnosis, Evaluation, and Treatment of High Blood Pressure in Children and Adolescents Pediatrics 114 555-576